A protein that can dial down oxidative stress in cells helps some cancers resist treatment with a widely used class of drugs called BTK inhibitors, according to a study led by investigators at Weill Cornell Medicine.
Strict regulations have prevented continental U.S. beekeepers from participating in the lucrative organic honey market, but new findings could provide evidence to open organic markets to U.S. producers.
An overactive immune response in the brain may play a role in Dravet syndrome, a rare and severe genetic epilepsy that typically begins in infancy, according to Weill Cornell Medicine researchers.
A new way to measure comorbidity can be used to accurately predict a patient’s risk of hospitalization and future healthcare costs across a population.
As psychedelic drugs gain more support from the medical community as a potential treatment for severe depression, Cornell researchers are making crucial discoveries that explain how compounds such as psilocybin work on the brain.
Across 37 counties, Cornell Cooperative Extension master gardeners are growing and evaluating select vegetables to find what grows best in New York state.
